Crystalline form of Fluvastatin sodium
US7432380B2 · kind B2 · utility
1Cited by
5References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 6, 2004 |
| Grant date | Oct 7, 2008 |
| Priority date | — |
| Expiry date | Oct 6, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A novel crystalline form of Fluvastatin sodium hydrate is described, referred to hereinafter as polymorphic Form G. Furthermore, processes for the preparation of this crystalline form and pharmaceutical compositions comprising this crystalline form are reported.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.